✦ LIBER ✦

Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism

✍ Scribed by Jill Everland Larsen; Maree Louise Colosimo; Ian Anthony Yang; Rayleen Bowman; Paul Victor Zimmerman; Kwun Meng Fong

Publisher: Springer Netherlands
Year: 2005
Tongue: English
Weight: 186 KB
Volume: 16
Category: Article
ISSN: 0957-5243
DOI: 10.1007/s10552-004-7842-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The association between RAD18 Arg302Gln

The association between RAD18 Arg302Gln polymorphism and the risk of human non-small-cell lung cancer

✍ Hirotaka Kanzaki; Mamoru Ouchida; Hiroko Hanafusa; Hiromasa Yamamoto; Hiromitsu 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 366 KB

The SOD2 Val/Val genotype enhances the r

The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms

✍ Geoffrey Liu; Wei Zhou; Sohee Park; Lisa I. Wang; David P. Miller; John C. Wain; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

## Abstract ## BACKGROUND Exogenous reactive oxygen species (ROS) induces DNA damage. Manganese superoxide dismutase (SOD2) catalyzes the dismutation of superoxide radicals, a major type of ROS, into hydrogen peroxide. __p53__ is a tumor suppressor gene, and X‐ray cross‐complementing group 1 (XRCC

Polymorphisms of the interleukin-1 β gen

Polymorphisms of the interleukin-1 β gene are associated with increased risk of non-small cell lung cancer

✍ Shanbeh Zienolddiny; David Ryberg; Valentina Maggini; Vidar Skaug; Federico Canz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 78 KB 👁 1 views

## Abstract Lung cancer is one of the leading causes of cancer death worldwide. Tobacco smoking is the main risk factor for lung cancer. Less than 20% of smokers develop lung cancer in their lifetime, however, indicating individual variations in lung cancer risk. Pro‐inflammatory cytokines produced

Influence ofTGFB1+869T>C functional poly

Influence ofTGFB1+869T>C functional polymorphism in non-small cell lung cancer (NSCLC) risk

✍ Ana L. Teixeira; António Araújo; Ana Coelho; Ricardo Ribeiro; Mónica Gomes; Cari 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 257 KB

Glutathione S-transferase P1 Ile105Val p

Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: convergence and divergence of the two recent meta-analyses

✍ Konstantinos P. Economopoulos; Theodoros N. Sergentanis 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 238 KB

Promoter −202 A/C polymorphism of insuli

Promoter −202 A/C polymorphism of insulin-like growth factor binding protein-3 gene and non-small cell lung cancer risk

✍ Jin Wook Moon; Yoon Soo Chang; Chul Woo Ahn; Kyeong Nam Yoo; Ju Hye Shin; Jee Hy 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 93 KB

Insulin-like growth factor binding protein-3 (IGFBP-3) inhibits the mitogenic and antiapoptotic activity of insulin-like growth factor (IGF) by blocking the binding of IGF to its receptor. However, under certain circumstances, IGFBP-3 can enhance the activity of IGF by protecting IGF from degradatio